3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Lung Neoplasms
4
Carcinoma, Non-Small-Cell Lung
3
Glioma
2
Glioblastoma
2
Urinary Bladder Neoplasms
1
Urethral Neoplasms
1
Ureteral Neoplasms
1
Sarcoma
1
Rhabdomyosarcoma
1
Prostatic Neoplasms
1
Pheochromocytoma
1
Paraganglioma
1
Papillary renal cell carcinoma, sporadic
1
Pancreatic Ductal Adenocarcinoma
1
Osteoradionecrosis
1
Mouth Neoplasms
1
Melanoma
1
Hereditary leiomyomatosis and renal cell cancer
1
Hematopoietic and Lymphoid System Neoplasm
1
Head and Neck Neoplasms
1
Gliosarcoma
1
Fallopian Tube Mucinous Adenocarcinoma
1
Ependymoma
1
Craniopharyngioma
1
Colorectal Neoplasms
1
Carcinoma, Renal Cell
1
Breast Neoplasms
1
Brain Neoplasms
1
Interventions
Gemcitabine
2
130-nm albumin-bound paclitaxel
2
paricalcitol
1
mitazalimab
1
ivosidenib
1
Tissue Banks
1
Specimen Handling
1
Positron Emission Tomography Computed Tomography
1
Parturition
1
Oxaliplatin
1
Neoadjuvant Therapy
1
Magnetic Resonance Spectroscopy
1
Losartan
1
Leucovorin
1
Irinotecan
1
Hydroxychloroquine
1
Glucose
1
Genetic Testing
1
Fluorouracil
1
Fecal Microbiota Transplantation
1
Escitalopram
1
Contrast Media
1
Capecitabine
1
Biopsy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Pancreatic Ductal Adenocarcinoma
×
Contrast Media
×
1 year
×
Clear all
NCT07324096
2026-03-27
AI-PACED
Mayo Clinic
Phase NA
Recruiting
100 enrolled